# Tyra Biosciences, Inc.: Form 8-K, filed Apr 2, 2026

- Company: [Tyra Biosciences, Inc.](/companies/tyra.md) (CIK 1863127)
- Form: 8-K
- Filed: 2026-04-02
- Accepted by EDGAR: Apr 2, 2026, 16:02 ET
- Period: 2026-04-01
- Accession: 0001193125-26-140027
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1863127/000119312526140027/d136343d8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1863127/000119312526140027/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1863127/000119312526140027/d136343d8k.htm

Filed Apr 2, 2026.
Source: SEC EDGAR, the filing index for accession 0001193125-26-140027. Last ingested by Listed: Nov 10, 2026, 17:08 ET. No prices; not investment advice.
